📰 Reverse Transcriptase News
Page 6 - Reverse Transcriptase News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Reverse Transcriptase. Real-time updates on events, politics, business and more.
December 17, 2021
Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, today announced the launch of its Codex® HiTemp Reverse Transcriptase for use in one-step quantitative reverse transcription PCR (RT-qPCR).
December 17, 2021
As coronavirus cases rise in Illinois and across the country in the lead-up to the Christmas and New Year holidays, questions over how long someone might be...
December 14, 2021
“Nothing in life is to be feared, it is only to be understood. Now is the time to understand more, so that we may fear less.” Those words, uttered by two-time Nobel Prize-winning chemist and physicist Marie Curie, are as relevant today as they were in her era (1867–1934). With most of the planet under some form of medical martial law, we would do well to follow her advice: understand more and fear less about the pandemic. The way to do that is to establish the verifiable, scientific facts...
December 14, 2021
What should you do if you or someone you have been in close contact with tests positive for coronavirus? How long are you contagious, what are the quarantine...
December 13, 2021
As COVID cases continue to climb in Illinois, many are wondering what they should do if they end up with a positive test result or have been in contact with...
December 6, 2021
This work has emphasized the clinical and translational potential of paper-based biosensors.
December 1, 2021
Researchers from the University of Michigan investigated the correlation between SARS-CoV-2 infection and the severity of reinfections.
November 25, 2021
In this perspective, a new study published on the medRxiv* preprint server analyzed the clinical efficacy of two serum antigen tests to identify SARS CoV-2 infection and evaluate the kinetics of serum nucleocapsid (N) antigen in severe and non-severe patients for disease severity prediction.
November 23, 2021
A review discusses paper-based devices and platforms targeting SARS-CoV-2 for low-cost PoC diagnosis and serological antibody testing.
October 20, 2021
By Fabio Giuseppe Carlo Carisio All links in Italian inside this article can be read in English with simultaneous machine translating Versione originale in Italiano On 21 July 2021, a palindrome date and therefore lucky, the 18 lines that rewrite the history of the Covid-19 pandemic were published. The CDC (Centers for Disease Control and […]